Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.24B
Revenue (ttm)	883.47M
Net Income (ttm)	73.01M
Shares Out	961.94M
EPS (ttm)	0.08
PE Ratio	16.99
Forward PE	13.27
Dividend	0.03 (2.33%)
Ex-Dividend Date	Mar 5, 2025

Volume	4,897,500
Average Volume	241,205
Open	1.380
Previous Close	1.290
Day's Range	1.280 - 1.400
52-Week Range	1.070 - 1.450
Beta	0.74
RSI	66.97
Earnings Date	May 16, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides ...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.